Chemoinformaics analysis of METHYL 9-OXONONANOATE
| Molecular Weight | 186.251 | nRot | 8 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 2 |
| Exact Molecular Weight | 186.126 | nRing | 0 |
| Solubility: LogS | -1.759 | nHRing | 0 |
| Solubility: LogP | 1.598 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 31.1083 |
| nHD | 0 | BPOL | 21.5297 |
| QED | 0.331 |
| Synth | 2.01 |
| Natural Product Likeliness | 1.157 |
| NR-PPAR-gamma | 0.092 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.98 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.578 |
| MDCK | 0.0000329 |
| BBB | 0.991 |
| PPB | 0.313934 |
| VDSS | 0.657 |
| FU | 0.776636 |
| CYP1A2-inh | 0.472 |
| CYP1A2-sub | 0.525 |
| CYP2c19-inh | 0.242 |
| CYP2c19-sub | 0.509 |
| CYP2c9-inh | 0.069 |
| CYP2c9-sub | 0.803 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.138 |
| CYP3a4-inh | 0.076 |
| CYP3a4-sub | 0.139 |
| CL | 7.75 |
| T12 | 0.836 |
| hERG | 0.086 |
| Ames | 0.306 |
| ROA | 0.051 |
| SkinSen | 0.968 |
| Carcinogencity | 0.138 |
| EI | 0.979 |
| Respiratory | 0.635 |
| NR-Aromatase | 0.079 |
| Antiviral | No |
| Prediction | 0.917674 |